Related Experiment Videos
Comparison of haemodynamic dose-response effects of beta- and alpha-beta-blockade in acute myocardial infarction
Insights
Comparing propranolol and labetalol in acute myocardial infarction patients, both drugs reduced cardiac workload. Labetalol, however, better preserved cardiac output by avoiding increased systemic vascular resistance.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Acute myocardial infarction requires careful hemodynamic management.
- Beta-blockers are standard therapy, but their effects on systemic vascular resistance can be detrimental.
- Alpha- and beta-blockade offers a potential alternative for hemodynamic modulation.
Purpose of the Study:
- To compare the hemodynamic dose-response effects of propranolol (beta-blockade) versus labetalol (alpha- plus beta-blockade).
- To evaluate circulatory effects in patients with uncomplicated acute myocardial infarction.
Main Methods:
- A randomized between-group study involving 16 patients.
- Comparative assessment of propranolol and labetalol at equivalent beta-blocking doses.
Main Results:
- Both drugs equally reduced myocardial stroke work index and oxygen requirements.
- Propranolol increased systemic vascular resistance, while labetalol did not.
- Labetalol caused less depression of cardiac output compared to propranolol at equivalent beta-blocking doses.
Conclusions:
- Combined alpha- and beta-blockade with labetalol may mitigate adverse circulatory effects of pure beta-blockade.
- This approach warrants further investigation for managing circulation post-myocardial infarction.
Abstract:
The comparative haemodynamic dose-response effects of beta- (propranolol) or alpha- plus beta-blockade (labetalol) were evaluated in a randomised between-group study of 16 patients with an uncomplicated acute myocardial infarction. In equivalent beta-blocking doses both drugs equally reduced myocardial stroke work index and presumably myocardial oxygen requirements. However, although propranolol reduced heart rate and cardiac output, these haemodynamic changes were accompanied by an augmentation of systemic vascular resistance. In contrast, labetalol reduced heart rate, cardiac output without change in systemic vascular resistance. Moreover, concomitant alpha- and beta-blockade with labetalol resulted in lesser depression of cardiac output at equivalent beta-blocking doses to propranolol. These results suggest that the addition of alpha to beta-blockade may attenuate some of the adverse reflex circulatory consequences of pure beta-blockade; the usefulness of this pharmacological approach to the manipulation of the circulation in the early post-infarction period merits further study.